Home › Funds › MFS Investment Management › ABCL
MFS Investment Management position in ABCL
ABCELLERA BIOLOGICS INC · Health Care
Latest position (Q4 2022)46.02K sh
Reported value held$466.14K
Portfolio Weight0.00%
First reportedQ3 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2022 | 81.16K | $803.00K | New |
| Q4 2022 | 46.02K | $466.14K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ABCL
- Capital World Investors 13.59M sh · $106.67M · Q2 2026
- Two Sigma Investments 10.44M sh · $81.93M · Q2 2026
- Bank of America Corp 6.14M sh · $48.21M · Q2 2026
- BlackRock Inc 3.81M sh · $29.87M · Q2 2026
- Marshall Wace 1.90M sh · $14.93M · Q2 2026
- Morgan Stanley 1.67M sh · $13.10M · Q2 2026
- Arrowstreet Capital 1.04M sh · $8.16M · Q2 2026
- Renaissance Technologies 990.93K sh · $7.78M · Q2 2026
- Millennium Management 518.57K sh · $4.07M · Q2 2026
- Citadel Advisors 372.30K sh · $2.92M · Q2 2026
- Geode Capital Management 315.72K sh · $2.48M · Q2 2026
- Northern Trust Corp 298.62K sh · $2.34M · Q2 2026